Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2022-07-22 / Front Mol Biosci 2022;9:816510An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2022-07-15 / Clin Cancer Res 2022 Jul;28(14):3053-3065Personalized tumor vaccine for pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-313Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
/in International Publications, Pancreatic Cancer /von 2022-07-09 / Heliyon 2022 Jul;8(7):e09915Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models
/in Colorectal Cancer, International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2022-07-07 / Cancer Res Commun 2022 Jul;2(7):602-615Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
/in International Publications, Newcastle Disease Virus /von 2022-07-04 / Front Mol Biosci 2022;9:889403IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution